This new-onset “growth” was removed and shown to be a solitary neurofibroma, which is not an indication of any of the genodermatoses marked by a multiplicity of such neoplasms.
A 47-year-old man sought medical attention because of a new-onset “growth” on the right arm. He was in good health and had no significant past medical history.
Key point: This uniform-appearing, flesh-colored, soft papule is almost certainly benign. A shave biopsy with light electrodesiccation to the base would likely serve both diagnostic and therapeutic purposes.
Treatment: The lesion was removed as noted above, and proved to be a solitary neurofibroma.
Note: A single neurofibroma is not an indication of any of the various genodermatoses that are characterized by a multiplicity of such neoplasms. No workup was entertained, and the removal site healed nicely.
Lebrikizumab Demonstrates Efficacy, Safety in Patients With Skin of Color With AD
June 11th 2025RAD 2025. Lebrikizumab improved skin clearance, itch, and pigmentation in patients with skin of color and atopic dermatitis, with strong safety data through 24 weeks, according to late-breaking data.